STERIS plc STE
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $271.33 (+31.4% upside)
Key Stats
- Today's Range
- $206.21 – $207.70
- 50-Day Range
- $206.21 – $241.39
- 52-Week Range
- $195.14 – $269.44
- Volume
- 169K shs
- Average Volume
- 609K shs
- Market Cap
- $20.28 billion
- P/E Ratio
- —
- Dividend Yield
- 1.34%
Valuation
- P/E Ratio
- —
- Price / Book
- 2.81
- Price / Sales
- 3.36
Dividend
- Dividend Yield
- 1.34%
- Annual Dividend
- $2.76
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-09-04
Short Interest
- Short Interest
- 1.79%
- Days to Cover
- 6.56
Financials (TTM)
- Revenue
- $6.04 billion
- Net Income
- $808.10 million
- Net Margin
- 13.38%
- Return on Equity
- 11.19%
- Debt-to-Equity
- 0.23
About STERIS plc
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
Related Stocks
Compare head-to-head: STE vs ZBH·STE vs MSA·STE vs SMTI·STE vs INGN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.